Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
about
In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.Gene therapy in the CNS.Gene therapy for Parkinson's disease: review and update.Advances in gene therapy for movement disorders.Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system.Delivery of transgenically modified adult bone marrow cells to the rodent central nervous system.Neurotrophic factors in neurodegeneration.GDNF therapy for Parkinson's disease.Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.Efficient introduction of macromolecules and oligonucleotides into brain capillary endothelial cells using HVJ-liposomes.Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats.Neurobehavioral assessment of transplanted porcine Sertoli cells into the intact rat striatum.Early history of veterinary public health in the United States.
P2860
Q33216908-A1F8313E-6D1C-4927-9C68-126D457A8006Q33787660-7B1C3097-B44E-4838-B2C1-00D464B5C24EQ33837123-FA603B61-6905-4176-871A-49653F770CE2Q34119491-A4DB7E80-FC3D-4168-84ED-4023B0A49844Q34656049-F279EE9F-3E60-439D-B526-648204425D98Q35243291-9DB2C3E2-BA2E-4BA9-A521-82C09DA34963Q35779364-D2D5A747-2ADF-45DF-A511-2DB656748968Q36654492-521D2FE8-7190-4C47-9BFD-C4D1A4BEB30BQ37203371-DB8ACDEC-32E8-407D-94CB-603FD948B927Q38495722-607E888F-0BB1-4C74-8C6D-81EAD621B433Q39737981-E6C57D0A-B24B-4AB2-9B5B-3A40A654DAEDQ40834189-A067403C-42E4-43DA-B07E-BF800EC132FCQ40911927-0E171784-4623-432A-83BB-E4F03F9A0327Q48269394-BCD88A50-95D0-4ABC-8854-9495C19A8F9AQ53469894-05064CBD-74C7-4818-8CEE-5C40BC551488
P2860
Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Adenoviral vector-mediated GDN ...... ate stage Parkinson's disease.
@en
type
label
Adenoviral vector-mediated GDN ...... ate stage Parkinson's disease.
@en
prefLabel
Adenoviral vector-mediated GDN ...... ate stage Parkinson's disease.
@en
P2093
P921
P1433
P1476
Adenoviral vector-mediated GDN ...... ate stage Parkinson's disease.
@en
P2093
P304
P356
10.1016/S0006-8993(97)01100-1
P577
1997-11-01T00:00:00Z